acf
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/evogene/biomicamed.com/wp-includes/functions.php on line 6121Biomica is a clinical-stage biopharmaceutical company dedicated to developing innovative microbiome-based therapeutics for the treatment of cancer, immune-mediated, and infectious diseases. Synergizing proprietary big data and computational capabilities, Biomica develops best-in-class therapeutics to address high-value, unmet medical needs.
Our unique approach is focused on understanding the functional elements of the microbiome. This enables us to select a minimal number of desired microbial candidates, thereby maximizing beneficial effects while minimizing potential adverse effects through carefully curated consortia.
Our drug candidates have been identified and designed using PRISM, a proprietary cutting-edge computational platform that integrates advanced AI capabilities, ‘Big Data’, and a comprehensive proprietary database. Through metagenomics sequencing, Biomica gains deeper insights into the microbiome, employing high-resolution taxonomy and functional profiling of the human microbiome. These insights enable us to develop novel solutions for complex host-microbiome interrelations and make clinically relevant predictions.
Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com
Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com
We’re excited to join Startup Nation Central’s Israel Health Tech delegation to the U.S. Our CEO, Dr. Elran Haber, will proudly represent Biomica on this journey.